Benjamin Harshbarger

Benjamin Harshbarger discloses dealings in Novelion Therapeutics Inc. to SEDI. The record holds 19 filings, for trades running from 16 December 2016 to 9 May 2019.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 14 May 2019, reports a transaction of €171 in Novelion Therapeutics Inc. The median gap between a trade and its publication by SEDI is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.